Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07HFU
|
||||
Former ID |
DNC007677
|
||||
Drug Name |
MCL-446
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528787] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H31N3O
|
||||
Canonical SMILES |
CNC(=O)NC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CC5)C=C1
|
||||
InChI |
1S/C22H31N3O/c1-23-21(26)24-17-8-7-16-12-20-18-4-2-3-9-22(18,19(16)13-17)10-11-25(20)14-15-5-6-15/h7-8,13,15,18,20H,2-6,9-12,14H2,1H3,(H2,23,24,26)/t18-,20+,22+/m0/s1
|
||||
InChIKey |
NXVBILHYMWWGLP-CZTZKLFOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528787] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528787] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [528787] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.